Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 27, 2026
Lisocabtagene Maraleucel Versus Standard of Care for Second-Line Relapsed/Refractory Large B-Cell Lymphoma: 3-Year Follow-Up From the Randomized, Phase III TRANSFORM Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 07, 2025
Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy.
Journal: Haematologica
Published: November 11, 2022
Exposure to antibiotics with anaerobic activity before respiratory viral infection is associated with respiratory disease progression after hematopoietic cell transplant.
Journal: Bone marrow transplantation
Published: May 10, 2022
Predictors of response to axicabtagene-ciloleucel CAR T cells in aggressive B cell lymphomas: A real-world study.
Journal: Journal of cellular and molecular medicine
Published: April 28, 2022
Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL.
Journal: Blood
Published: October 19, 2021
Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant.
Journal: JAMA oncology
Published: May 06, 2021
Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma.
Journal: Transplantation and cellular therapy
Published: August 20, 2020
Last Updated: 09/26/2026